Fig 2. Results of genome-wide association study of certolizumab pegol response, as measured by DAS28 (week 12) scores.

(A) Manhattan plot of significance scores from linear regression analysis. (B) Quantile-quantile plot of observed significance scores vs expected under the null hypothesis. The red line indicates the Bonferroni-adjusted threshold for statistical significance.